Jayamas Medica Industri TBK PT
IDX:OMED
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
173
222
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Balance Sheet
Balance Sheet Decomposition
Jayamas Medica Industri TBK PT
| Current Assets | 2.2T |
| Cash & Short-Term Investments | 1.2T |
| Receivables | 281.6B |
| Other Current Assets | 696.9B |
| Non-Current Assets | 519.6B |
| Long-Term Investments | 59.8B |
| PP&E | 445.4B |
| Intangibles | 130.4m |
| Other Non-Current Assets | 14.2B |
| Current Liabilities | 307.5B |
| Accounts Payable | 96.7B |
| Accrued Liabilities | 12.9B |
| Other Current Liabilities | 197.9B |
| Non-Current Liabilities | 81.7B |
| Long-Term Debt | 17B |
| Other Non-Current Liabilities | 64.7B |
Balance Sheet
Jayamas Medica Industri TBK PT
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
132 045
|
697 028
|
732 841
|
830 549
|
1 120 572
|
|
| Cash |
132 045
|
290 928
|
319 820
|
410 735
|
329 334
|
|
| Cash Equivalents |
0
|
406 101
|
413 021
|
419 814
|
791 238
|
|
| Short-Term Investments |
184 169
|
0
|
105 000
|
500 000
|
63 646
|
|
| Total Receivables |
118 986
|
304 263
|
184 004
|
187 413
|
212 148
|
|
| Accounts Receivables |
118 855
|
299 012
|
181 838
|
187 045
|
208 108
|
|
| Other Receivables |
131
|
5 252
|
2 166
|
368
|
4 040
|
|
| Inventory |
93 555
|
241 673
|
411 186
|
521 916
|
604 756
|
|
| Other Current Assets |
24 531
|
24 809
|
57 306
|
72 969
|
46 144
|
|
| Total Current Assets |
553 286
|
1 267 773
|
1 490 337
|
2 112 847
|
2 047 267
|
|
| PP&E Net |
103 631
|
141 892
|
225 807
|
306 671
|
417 912
|
|
| PP&E Gross |
103 631
|
141 892
|
225 807
|
306 671
|
417 912
|
|
| Accumulated Depreciation |
80 575
|
97 118
|
131 953
|
172 959
|
223 295
|
|
| Intangible Assets |
0
|
1 266
|
669
|
539
|
167
|
|
| Note Receivable |
0
|
0
|
0
|
57 962
|
66 125
|
|
| Long-Term Investments |
690
|
696
|
5
|
24 482
|
45 498
|
|
| Other Long-Term Assets |
4 464
|
4 954
|
9 581
|
4 817
|
4 514
|
|
| Total Assets |
662 071
N/A
|
1 416 582
+114%
|
1 726 400
+22%
|
2 507 319
+45%
|
2 581 483
+3%
|
|
| Liabilities | ||||||
| Accounts Payable |
17 991
|
170 127
|
169 189
|
190 982
|
95 169
|
|
| Accrued Liabilities |
27 399
|
19 553
|
3 890
|
3 265
|
8 540
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1 594
|
2 994
|
15 128
|
21 245
|
13 621
|
|
| Other Current Liabilities |
14 373
|
71 744
|
84 588
|
15 454
|
18 805
|
|
| Total Current Liabilities |
61 357
|
264 419
|
272 796
|
230 946
|
136 134
|
|
| Long-Term Debt |
675
|
162 334
|
171 537
|
178 453
|
175 607
|
|
| Minority Interest |
4 389
|
11 706
|
21 040
|
25 053
|
27 189
|
|
| Other Liabilities |
34 238
|
39 262
|
36 625
|
28 499
|
24 334
|
|
| Total Liabilities |
100 660
N/A
|
477 720
+375%
|
501 998
+5%
|
462 951
-8%
|
363 263
-22%
|
|
| Equity | ||||||
| Common Stock |
10 000
|
4 500
|
575 000
|
676 471
|
676 471
|
|
| Retained Earnings |
703 481
|
1 388 717
|
1 125 910
|
1 161 692
|
1 335 275
|
|
| Additional Paid In Capital |
152 439
|
450 859
|
455 919
|
223 188
|
223 188
|
|
| Other Equity |
369
|
3 496
|
20 588
|
16 983
|
16 715
|
|
| Total Equity |
561 411
N/A
|
938 862
+67%
|
1 224 402
+30%
|
2 044 368
+67%
|
2 218 219
+9%
|
|
| Total Liabilities & Equity |
662 071
N/A
|
1 416 582
+114%
|
1 726 400
+22%
|
2 507 319
+45%
|
2 581 483
+3%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
27 059
|
27 059
|
27 059
|
27 059
|
27 059
|
|
You don't have any saved screeners yet
